» Articles » PMID: 14693935

Retinopathy in Diabetes

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2003 Dec 25
PMID 14693935
Citations 393
Authors
Affiliations
Soon will be listed here.
Citing Articles

Lipoxin A4 (LXA4) as a Potential Drug for Diabetic Retinopathy.

Das U Medicina (Kaunas). 2025; 61(2).

PMID: 40005295 PMC: 11857424. DOI: 10.3390/medicina61020177.


Association Between Macular Ganglion Cell-Inner Plexiform Layer and Non-Proliferative Retinopathy Without Macular Edema in Type 2 Diabetes via Diabetes Duration and HbAc Link.

Vrabec R, Bulum T, Ljubic S, Tomic M Biomedicines. 2025; 13(2).

PMID: 40002811 PMC: 11853396. DOI: 10.3390/biomedicines13020398.


Intraocular drug delivery systems for Diabetic retinopathy: Current and future prospective.

Taheri S, Poorirani S, Mostafavi S Bioimpacts. 2025; 15:30127.

PMID: 39963560 PMC: 11830143. DOI: 10.34172/bi.30127.


Early Prediction of Cardio Vascular Disease (CVD) from Diabetic Retinopathy using improvised deep Belief Network (I-DBN) with Optimum feature selection technique.

Revathi T, Sathiyabhama B, Kaliraj S, Sureshkumar V BMC Cardiovasc Disord. 2025; 25(1):30.

PMID: 39827098 PMC: 11748577. DOI: 10.1186/s12872-024-04374-0.


Intravitreal therapy for the management of diabetic retinopathy: A concise review.

Arora A, Morya A, Gupta P, Menia N, Nishant P, Gupta V World J Exp Med. 2024; 14(4):99235.

PMID: 39713073 PMC: 11551706. DOI: 10.5493/wjem.v14.i4.99235.